REmission in Membranous Nephropathy International Trial (REMIT)

Conditions: Primary Membranous Nephropathy Interventions: Drug: Obinutuzumab; Drug: Oral prednisolone and cyclophosphamide Sponsors: The University of Queensland; University of Adelaide Not yet recruiting

https://clinicaltrials.gov/study/NCT06120673

Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials

More News: Prednisolone | Research